Cargando…
Orchestrating stem cell fate: Novel tools for regenerative medicine
Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its r...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716083/ https://www.ncbi.nlm.nih.gov/pubmed/31523367 http://dx.doi.org/10.4252/wjsc.v11.i8.464 |
_version_ | 1783447323038187520 |
---|---|
author | Cruciani, Sara Santaniello, Sara Montella, Andrea Ventura, Carlo Maioli, Margherita |
author_facet | Cruciani, Sara Santaniello, Sara Montella, Andrea Ventura, Carlo Maioli, Margherita |
author_sort | Cruciani, Sara |
collection | PubMed |
description | Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its role in maintaining self-renewal and differentiation capabilities. Chemical and physical stimuli can modulate cell commitment, acting on gene expression of Oct-4, Sox-2 and Nanog, the main stemness markers, and tissue-lineage specific genes. This activation or repression is related to the activity of chromatin-remodeling factors and epigenetic regulators, new targets of many cell therapies. The aim of this review is to afford a view of the current state of in vitro and in vivo stem cell applications, highlighting the strategies used to influence stem cell commitment for current and future cell therapies. Identifying the molecular mechanisms controlling stem cell fate could open up novel strategies for tissue repairing processes and other clinical applications. |
format | Online Article Text |
id | pubmed-6716083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-67160832019-09-13 Orchestrating stem cell fate: Novel tools for regenerative medicine Cruciani, Sara Santaniello, Sara Montella, Andrea Ventura, Carlo Maioli, Margherita World J Stem Cells Review Mesenchymal stem cells are undifferentiated cells able to acquire different phenotypes under specific stimuli. In vitro manipulation of these cells is focused on understanding stem cell behavior, proliferation and pluripotency. Latest advances in the field of stem cells concern epigenetics and its role in maintaining self-renewal and differentiation capabilities. Chemical and physical stimuli can modulate cell commitment, acting on gene expression of Oct-4, Sox-2 and Nanog, the main stemness markers, and tissue-lineage specific genes. This activation or repression is related to the activity of chromatin-remodeling factors and epigenetic regulators, new targets of many cell therapies. The aim of this review is to afford a view of the current state of in vitro and in vivo stem cell applications, highlighting the strategies used to influence stem cell commitment for current and future cell therapies. Identifying the molecular mechanisms controlling stem cell fate could open up novel strategies for tissue repairing processes and other clinical applications. Baishideng Publishing Group Inc 2019-08-26 2019-08-26 /pmc/articles/PMC6716083/ /pubmed/31523367 http://dx.doi.org/10.4252/wjsc.v11.i8.464 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Cruciani, Sara Santaniello, Sara Montella, Andrea Ventura, Carlo Maioli, Margherita Orchestrating stem cell fate: Novel tools for regenerative medicine |
title | Orchestrating stem cell fate: Novel tools for regenerative medicine |
title_full | Orchestrating stem cell fate: Novel tools for regenerative medicine |
title_fullStr | Orchestrating stem cell fate: Novel tools for regenerative medicine |
title_full_unstemmed | Orchestrating stem cell fate: Novel tools for regenerative medicine |
title_short | Orchestrating stem cell fate: Novel tools for regenerative medicine |
title_sort | orchestrating stem cell fate: novel tools for regenerative medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716083/ https://www.ncbi.nlm.nih.gov/pubmed/31523367 http://dx.doi.org/10.4252/wjsc.v11.i8.464 |
work_keys_str_mv | AT crucianisara orchestratingstemcellfatenoveltoolsforregenerativemedicine AT santaniellosara orchestratingstemcellfatenoveltoolsforregenerativemedicine AT montellaandrea orchestratingstemcellfatenoveltoolsforregenerativemedicine AT venturacarlo orchestratingstemcellfatenoveltoolsforregenerativemedicine AT maiolimargherita orchestratingstemcellfatenoveltoolsforregenerativemedicine |